Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tree, T. I.M.
Right arrow Articles by Roep, B. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tree, T. I.M.
Right arrow Articles by Roep, B. O.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:1692-1699, 2004
© 2004 by the American Diabetes Association, Inc.

HLA-DQ–Regulated T-Cell Responses to Islet Cell Autoantigens Insulin and GAD65

Timothy I.M. Tree1, Gaby Duinkerken2, Sabine Willemen2, René R.P. de Vries2, and Bart O. Roep2

1 Department of Immunology, Guy’s, King’s, and St. Thomas’ School of Medicine, Denmark Hill Campus, Rayne Institute, London, U.K
2 Department of Immunohaematology and Blood Transfusion, Leiden University Medical Centre, Leiden, the Netherlands

HLA-DQ is strongly associated with genetic predisposition to type 1 diabetes. It is assumed that HLA-DQ molecules exert their effects on the disease via the presentation of peptides from islet autoantigens to CD4+ T-cells, but little information regarding HLA-DQ–restricted, islet antigen–specific, autoreactive T-cells is available. To investigate the role of HLA-DQ in the immune response to islet autoantigens, we measured T-cell proliferation to insulin and GAD65 in the presence and absence of monoclonal antibodies that block HLA-DQ–mediated antigen presentation in recent-onset type 1 diabetic patients and their siblings. Positive proliferative T-cell responses to GAD65 were observed in 60% of type 1 diabetic patients and 52% of siblings. This proliferation was significantly reduced in the presence of anti-DQ antibody, demonstrating the presence of primed, effector HLA-DQ–restricted T-cell responses to GAD65. Positive proliferative responses to insulin were observed in 25% of type 1 diabetic patients and 10% of siblings. However, blocking HLA-DQ–restricted T-cell responses led to a significant increase in proliferation to insulin, implying the presence of primed suppressive HLA-DQ–restricted T-cell responses to insulin. These results indicate that HLA-DQ acts as a restriction element for both proliferative and suppressor cells, with the relative balance of these cells dependent on the nature of the autoantigen.


Address correspondence and reprint requests to Professor Bart O. Roep, Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, E3-Q, P.O. Box 9600, NL-2300 RC Leiden, Netherlands. E-mail: boroep{at}lumc.nl

Abbreviations: MHC, major histocompatibility complex; SI, stimulation index


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
A. Quinn, M. McInerney, D. Huffman, B. McInerney, S. Mayo, K. Haskins, and E. Sercarz
T cells to a dominant epitope of GAD65 express a public CDR3 motif
Int. Immunol., June 1, 2006; 18(6): 967 - 979.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.